KBC Group’s Calumet Specialty Products CLMT Stock Holding History

KBC Group’s Portfolio CLMT Stock Details CLMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$69K	Hold	1,921	–	–	﹤0.01%	1595
2026 Q1	$69K	Buy	+1,921	New	+$49.7K	﹤0.01%	1514

Other funds holding CLMT

TSC

Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

WDOM

Wasserstein Debt Opportunities Management New York $264M AUM 188.78% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AAA

Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

KBC Group's CLMT Position: Q2 2026 in Review

KBC Group held its Calumet Specialty Products (CLMT) position steady in Q2 2026 at 1,921 shares worth $69K. The position accounts for ﹤0.01% of the portfolio, ranked #1595.

KBC Group first reported a position in CLMT in Q1 2026 and has held it in 2 quarters since. 188 funds tracked by Wall St. Rank hold CLMT as of Q2 2026.

KBC Group held 1,921 shares of Calumet Specialty Products worth $69K as of Q2 2026.
KBC Group left its Calumet Specialty Products share count unchanged in Q2 2026.
Calumet Specialty Products made up ﹤0.01% of KBC Group's portfolio in Q2 2026, its #1595 holding.
KBC Group first reported a position in Calumet Specialty Products in Q1 2026 and has held it in 2 quarters since.
188 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q2 2026.

Based on KBC Group's 13F filing for Q2 2026, filed 5 Aug 2026.